Industry News
Pharmaceutical Industry News

SK Biopharmaceutical is targeting…
SK Biopharmaceutical is targeting a new FDA indication in primary generalized tonic-clonic seizures for Xcopri after its original 2019 approval for focal seizures.
After another swing and a miss for…
After another swing and a miss for AstraZeneca's investigation of Fasenra in chronic obstructive pulmonary disease, the company is pivoting to other options in its portfolio that might have potential to treat the respiratory disease.
Diagnosis and treatment delays…
Diagnosis and treatment delays cost patient lives. Learn how forward-thinking pharma brands are using smarter marketing to change the picture.
British Big Pharma GSK is…
British Big Pharma GSK is welcoming President Donald Trump to the U.K. with a hefty gift: a five-year, $30 billion planned investment in U.S. R&D and manufacturing.
AGC has started a “structured…
AGC has started a “structured process” to seek for buyers for its large-scale mammalian production sites in Boulder and Longmont, Colorado, a company spokesperson said.
After the FDA announced it was…
After the FDA announced it was cracking down on what it has determined to be “misleading” or “deceptive” direct-to-consumer pharmaceutical ads, the floodgates have opened.
Last week, on the same day the…
Last week, on the same day the Trump administration laid out its plan to rein in direct-to-consumer drug advertising, the FDA sent out its first untitled letter in months, this one taking issue with a
The FDA reprimand focuses on five…
The FDA reprimand focuses on five manufacturing deficiencies observed during the inspection, which took place from Sept. 4 to Sept. 12. The company didn’t detail the infractions in its filing, saying only that it plans
Eli Lilly has revealed the…
Eli Lilly has revealed the location of the first of four large-scale manufacturing facilities that it plans to build in the U.S. The company has selected Goochland County, Virginia, as the site of a $5
After HHS secretary Robert F….
After HHS secretary Robert F. Kennedy Jr. overhauled the CDC's vaccine advisory panel over the summer, he's adding to the group's lineup with five new members.
Forty-two years after approving…
Forty-two years after approving the potent diuretic Bumex (bumetanide) as both an oral and infused treatment for edema, the FDA has endorsed a new version of the drug to be delivered as a nasal spray.
While the tone was often…
While the tone was often reflective at this year’s Fierce Pharma Week proceedings in Philadelphia, a sense of resilience and commitment to the critical work pharma communications and marketing teams do resonated throughout the event.
FDA Commissioner Marty Makary,…
FDA Commissioner Marty Makary, M.D., took aim at drugmakers, online pharmacies and social media influencers in a new op-ed shedding more light on the Trump administration’s recent moves to rein in direct-to-consumer drug advertisements.
More than 40 years after…
More than 40 years after establishing the first U.S. pharmaceutical joint venture in China, Bristol Myers Squibb is handing over its controlling stake in the business.
FDA Director Marty Makary: I’m Cracking Down on Pharma Ads
The Food and Drug Administration is taking action to rein in misleading ads.
Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertiser
Regulators sent about 100 warning letters this week to drug advertisers, including to Hims & Hers, a major online provider of weight-loss drugs.
F.D.A. Reviews Reports of Covid Vaccine Deaths
The agency plans to highlight possible links between the shots and accounts of deaths involving children and birth defects to an influential C.D.C. panel meeting next week.
The movie, set in a snowed-in…
The movie, set in a snowed-in hospital on Christmas Day, will feature cameos from members of Abbott's HeartMates patient community, including football player Damar Hamlin.
In a Fierce Pharma Week panel,…
In a Fierce Pharma Week panel, experts including Coalition for Healthcare Communication Director James Potter discussed why President Donald Trump's threats to drug advertising may be more bark than bite.
As Robert F. Kennedy Jr.’s…
As Robert F. Kennedy Jr.’s revamped CDC vaccine advisory panel gears up to meet next week, U.S. health officials are reportedly planning to connect the deaths of 25 children to the use of COVID shots.


